Leading United State Authorities Meet Zelenskyy

Vice Head Of State Kamala Harris has tested favorable for COVID-19. This, on its face, need to be immaterial. However, the White Home managed to regurgitate a red flag when it announced her course of treatment– specifically provided the line of succession to the nation’s highest office.

According to an announcement from Harris’ press secretary on Tuesday, the veep had actually been prescribed an anti-viral drug that is just indicated for those in high-risk classifications. The news raised questions concerning how severe Harris’ situation of COVID is and also what impact– if any type of– it will certainly have at the White House.

(As info appears, The Western Journal will continue to upgrade viewers with news as well as analysis concerning Harris’ COVID diagnosis— in addition to various other developments out of Washington at this vital time. If you sustain our conventional, Christian journalism, please think about subscribing.)

As the Los Angeles Times noted, this ought to be no big deal, because Harris isn’t supposed to be in a high-risk group.

“Harris, 57, has been vaccinated and increased twice. The shots significantly decrease the possibilities of her ending up being seriously ill. When previous President Trump, 75, was hospitalized with COVID-19 in October 2020, he was at much higher danger, provided his age as well as the absence of available injections,” the record kept in mind.

And also, all appeared to be well or else, thinking about officials claimed Harris was experiencing no signs. Harris’ press assistant, Kirsten Allen, said the vice head of state “will certainly separate as well as remain to function from the Vice President’s home” while she’s ill.

“The Vice Head of state will certainly go back to the White Residence when she checks adverse,” Allen claimed.

However, Allen additionally tweeted this on Tuesday:

“Today, after examination with her physicians, the Vice Head of state was prescribed and has taken Paxlovid,” Allen claimed.

Paxlovid is the trademark name of a Pfizer-manufactured antiviral medicine composed of “nirmatrelvir tablet computers and also ritonavir tablets, co-packaged for oral usage,” according to the Fda’s site.

It was offered emergency usage consent in December– however below’s where it obtains problematic.

That emergency usage authorization was specifically indicated for those “with positive results of straight SARS-CoV-2 screening, as well as who go to high danger for progression to severe COVID-19, including hospitalization …

Resource

More Reading

Post navigation

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *